Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist Entity disclosure reporting period:   01/01/2020 - 06/30/2020
Authorizing Officer name John F. Heffernan
Title Principal
Business name Park Street Strategies, LLC
Address 15 Clifton Avenue   
City, state, zip code Marblehead, MA 01945         
Country USA
Phone 617-981-0015 

Client Compensation
NameAmount
Biotechnology Innovation Organization (BIO) $20,000.00
UCB, Inc. $21,000.00
Massachusetts Biotechnology Council $60,000.00
Flexion Therapeutics, Inc. $20,000.00
Total salaries received $121,000.00

 
Compensation/Salaries Paid
Lobbyist or Entity nameSalaries
John Heffernan $52,000.00
Total salaries paid $52,000.00
 
Activities, Bill Numbers and Titles
No activities, bill numbers or bill titles were disclosed for this reporting period.
 
Operating Expenses
DateRecipientType of expenseAmount
01/27/2020 Staples, Inc. Photocopies, scans $14.57
02/03/2020 Staples, Inc. Photocopies, scans $1.36
02/06/2020 Staples, Inc. Photocopies, scans $16.34
02/18/2020 Staples, Inc. Photocopies, scans $4.76
03/11/2020 Staples, Inc. Photocopies, scans $3.97
03/12/2020 Staples, Inc. Photocopies, scans $11.67
03/12/2020 Staples, Inc. Photocopies, scans $1.96
06/26/2020 Staples, Inc. Photocopies, scans $2.78
06/29/2020 Staples, Inc. Photocopies, scans $3.40
03/13/2020 Greater Boston Chamber of Commerce Professional dues $350.00
05/05/2020 Boston Irish Business Association (BIBA) Professional dues $150.00
03/12/2020 MassBIO (Massachusetts Biotechnology Council) Professional dues $1,600.00
02/21/2020 Riley & Dever Legal fees $670.00
06/30/2020 US Postal Service Postage, shipping, delivery $20.93
06/30/2020 Regus Rent $1,065.00
06/30/2020 AT&T Telephone, cell phone, handheld $627.60
06/25/2020 Ward & Lawless LLC Other operating expenses $3,115.00
  Total operating expenses $7,659.34
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
 
Lobbyist: John Heffernan
Client: Biotechnology Innovation Organization (BIO)
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1062 An Act relative to transparent health care data Neutral $0.00 N/A
House Bill 1930 An Act providing for unused medication return by health care facilities Neutral $0.00 N/A
House Bill 4268 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
Executive Office of the Governor Order No. 35 Clarifies the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces Neutral $0.00 N/A
Senate Bill 611 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
Senate Bill 1206 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
Senate Bill 2484 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 1088 An Act relative to prescription drug access Support $0.00 N/A
House Bill 1934 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
House Bill 2 An Act making appropriations for the fiscal year 2021 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Executive Office of the Governor Order No. 591: Declaration of a State of Emergency to Respond to COVID-19 Neutral $0.00 N/A
Senate Bill 640 An Act to ensure access to generic medications Neutral $0.00 N/A
Senate Bill 1218 An Act relative to sharps stewardship Oppose $0.00 N/A
Senate Bill 2598 An Act Authorizing Waiver of the One Week Waiting Period for Unemployment Benefits Support $0.00 N/A
House Bill 959 An Act requiring continual coverage of prescription medication Neutral $0.00 N/A
House Bill 1186 An Act strengthening HPC and CHIA market oversight Neutral $0.00 N/A
House Bill 1050 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
Executive Office of the Governor Order No. 13: Designates certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people Neutral $0.00 N/A
Senate Bill 543 An Act reducing health care costs through improved medication management Support $0.00 N/A
Senate Bill 715 An Act relative to pharmaceutical price transparency and cost sharing Neutral $0.00 N/A
Senate Bill 563 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 1013 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1193 An Act providing for the establishment of a drug cost review commission Neutral $0.00 N/A
House Bill 4134 An Act to improve health care by investing in VALUE Neutral $0.00 N/A
Executive Office of the Governor Order No. 30: Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
Senate Bill 570 An Act relative to out-of-pocket expenses for prescription drug coverage Support $0.00 N/A
Senate Bill 728 An Act providing affordable access to generic medicines Neutral $0.00 N/A
Senate Bill 2397 Pharmaceutical Access, Costs and Transparency Oppose $0.00 N/A
House Bill 1133 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 2666 An Act designating the last day of February as rare disease day in the Commonwealth Neutral $0.00 N/A
House Bill 4506 An Act authorizing and accelerating transportation investment Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 22 Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
Senate Bill 652 An Act relative to pharmaceutical "gag clauses" Support $0.00 N/A
Senate Bill 1235 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2671 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
House Bill 629 An Act relative to pharmaceutical pricing Oppose $0.00 N/A
House Bill 1162 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3654 An Act relative to compensation for victims of opioids Neutral $0.00 N/A
House Bill 4547 An Act authorizing and accelerating transportation investment Support $0.00 N/A
Senate Bill 120 An Act relative to consumer data privacy Neutral $0.00 N/A
Senate Bill 696 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 1701 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
Senate Bill 2796 An Act Putting Patients First (Printed-as-amended version of SB2769) Support $0.00 N/A
House Bill 229 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 1154 An Act to reduce drug costs through transparency Oppose $0.00 N/A
House Bill 3500 An Act to protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
House Bill 4529 An Act enabling partnerships for growth Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 291 MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 Neutral $0.00 N/A
Senate Bill 654 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1301 An Act to prevent undue influence on prescriber behavior Oppose $0.00 N/A
Senate Bill 2746 An Act financing improvements to municipal roads and bridges Support $0.00 N/A
House Bill 915 An Act ensuring access to medications Neutral $0.00 N/A
House Bill 1167 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 3877 An Act relative to capping the price of life saving prescription drugs Oppose $0.00 N/A
House Bill 4567 An Act relative to the application of the Domestic Workers Bill of Rights as it pertains to Au Pairs Support $0.00 N/A
Senate Bill 154 An Act relative to bad faith assertions of patent infringement Support $0.00 N/A
Senate Bill 703 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Senate Bill 1780 An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax Neutral $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing Neutral $0.00 N/A
House Bill 916 An Act relative to co-pay assistance Support $0.00 N/A
House Bill 1168 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $0.00 N/A
House Bill 988 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 4565 An Act relative to room and board costs for au pairs Support $0.00 N/A
Senate Bill 159 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
Senate Bill 706 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
Senate Bill 1879 An Act to ensure more women serve on corporate boards of directors Neutral $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability Neutral $0.00 N/A
House Bill 1111 An Act allowing for retail pharmacy discounts and co-pay assistance Support $0.00 N/A
House Bill 1972 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Oppose $0.00 N/A
House Bill 2836 An Act re-powering Massachusetts with 100 percent renewable energy Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 21 Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
Senate Bill 646 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1230 An Act to protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
Senate Bill 2618 An Act providing additional support to those affected by the novel coronavirus through the unemployment insurance system Support $0.00 N/A
House Bill 391 An Act relative to reprogrammed human skin cells for embryonic stem cell research Neutral $0.00 N/A
House Bill 1660 An Act promoting pay transparency and pipeline advancement Neutral $0.00 N/A
House Bill 3551 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
House Bill 4530 An Act relative to transportation finance Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) N/A: Monitoring the Department of Public Health emergency order regarding modifications to pharmacy practice Neutral $0.00 N/A
Senate Bill 695 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Oppose $0.00 N/A
Senate Bill 1304 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
Senate Bill 2769 An Act Putting Patients First Support $0.00 N/A
House Bill 966 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
House Bill 1192 An Act relative to the examination of health care cost trends in MassHealth Neutral $0.00 N/A
House Bill 1116 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
Executive Office of the Governor Order No. 21: Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
Senate Bill 552 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 721 An Act relative to mandatory prescription drug coverage Oppose $0.00 N/A
Senate Bill 2338 Protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
House Bill 1148 An Act regarding Massachusetts drug price relief Oppose $0.00 N/A
House Bill 3481 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
House Bill 4508 An Act relative to transportation finance Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 289 MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 Neutral $0.00 N/A
Senate Bill 653 An Act relative to prescription drug pricing Neutral $0.00 N/A
Senate Bill 1295 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
Senate Bill 2739 Authorizing and Accelerating Transportation Investment (Recommended new text of H4547) Support $0.00 N/A
House Bill 1016 An Act establishing a commission to study maximum allowable costs lists Neutral $0.00 N/A
House Bill 1853 An Act relative to fail first and patient safety Support $0.00 N/A
House Bill 4211 An Act to improve patient access to cancer clinical trial programs Support $0.00 N/A
Executive Office of the Governor Order No. 32: Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
Senate Bill 582 An Act ensuring access to medications Neutral $0.00 N/A
Senate Bill 733 An Act relative to consumer protection for prescription drug purchases Support $0.00 N/A
Senate Bill 2409 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 1055 An Act to ensure access to generic medications Neutral $0.00 N/A
House Bill 1860 An Act relative to the dispensing of prescription drugs Neutral $0.00 N/A
House Bill 4228 An Act relative to fail first and patient safety Support $0.00 N/A
Executive Office of the Governor Order No. 33 Authorizes the re-opening of certain brick-and-mortar premises designated as Phase I workplace Neutral $0.00 N/A
Senate Bill 601 An Act to reduce the cost of pharmacy benefits Neutral $0.00 N/A
Senate Bill 1149 An Act strengthening prescription drug safety and drug stewardship Oppose $0.00 N/A
Senate Bill 2433 An Act relative to step therapy and patient safety Support $0.00 N/A
House Bill 949 An Act relative to non-medical switching Support $0.00 N/A
House Bill 1178 An Act relative to promoting transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 1036 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 4806 Governor's Interim Spending Budget (FY2021) Neutral $0.00 N/A
Senate Bill 541 An Act relative to co-pay assistance Support $0.00 N/A
Senate Bill 712 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Senate Docket 2264 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John Heffernan
Client: UCB, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 4529 An Act enabling partnerships for growth Neutral $0.00 N/A
Senate Bill 2433 An Act relative to step therapy and patient safety Support $0.00 N/A
House Bill 1145 An Act relative to the treatment of epilepsy and seizure disorders Support $0.00 N/A
Senate Bill 1235 An Act relative to step therapy and patient safety Support $0.00 N/A
House Bill 1853 An Act relative to fail first and patient safety Support $0.00 N/A
House Bill 949 An Act relative to non-medical switching Support $0.00 N/A
House Bill 4228 An Act relative to fail first and patient safety Support $0.00 N/A
Senate Bill 706 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
    Total amount $0.00  
Lobbyist: John Heffernan
Client: Massachusetts Biotechnology Council
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1111 An Act allowing for retail pharmacy discounts and co-pay assistance Support $0.00 N/A
House Bill 1972 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Oppose $0.00 N/A
House Bill 2836 An Act re-powering Massachusetts with 100 percent renewable energy Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 21: Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
Senate Bill 646 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1230 An Act to protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
Senate Bill 2598 An Act Authorizing Waiver of the One Week Waiting Period for Unemployment Benefits Support $0.00 N/A
House Bill 1133 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 2666 An Act designating the last day of February as rare disease day in the Commonwealth Neutral $0.00 N/A
House Bill 4506 An Act authorizing and accelerating transportation investment Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 22: Removal of Prior Authorization on Certain Therapeutic Classes; Utilization Management Related to COVID-19, Relaxing referral and prior approval requirements and procedures-updated-covera
ge-and-payment-policies
Neutral $0.00 N/A
Senate Bill 652 An Act relative to pharmaceutical "gag clauses" Support $0.00 N/A
Senate Bill 1235 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2618 An Act providing additional support to those affected by the novel coronavirus through the unemployment insurance system Support $0.00 N/A
House Bill 1013 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 1193 An Act providing for the establishment of a drug cost review commission Neutral $0.00 N/A
House Bill 4134 An Act to improve health care by investing in VALUE Neutral $0.00 N/A
Executive Office of the Governor Order No. 30: Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
Senate Bill 570 An Act relative to out-of-pocket expenses for prescription drug coverage Support $0.00 N/A
Senate Bill 728 An Act providing affordable access to generic medicines Neutral $0.00 N/A
Senate Bill 2338 Protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
House Bill 1055 An Act to ensure access to generic medications Neutral $0.00 N/A
House Bill 1860 An Act relative to the dispensing of prescription drugs Neutral $0.00 N/A
House Bill 4228 An Act relative to fail first and patient safety Support $0.00 N/A
Executive Office of the Governor Order No. 33: Authorizes the re-opening of certain brick-and-mortar premises designated as Phase I workplace Neutral $0.00 N/A
Senate Bill 601 An Act to reduce the cost of pharmacy benefits Neutral $0.00 N/A
Senate Bill 1149 An Act strengthening prescription drug safety and drug stewardship Oppose $0.00 N/A
Senate Bill 2409 An Act relative to pharmaceutical access, costs and transparency Oppose $0.00 N/A
House Bill 229 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 1154 An Act to reduce drug costs through transparency Oppose $0.00 N/A
House Bill 3500 An Act to protect children, families, and firefighters from harmful flame retardants Support $0.00 N/A
House Bill 4529 An Act enabling partnerships for growth Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 291: MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 Neutral $0.00 N/A
Senate Bill 654 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1301 An Act to prevent undue influence on prescriber behavior Oppose $0.00 N/A
Senate Bill 2739 Authorizing and Accelerating Transportation Investment (Recommended new text of H4547) Support $0.00 N/A
House Bill 916 An Act relative to co-pay assistance Support $0.00 N/A
House Bill 1168 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $0.00 N/A
House Bill 988 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 4565 An Act relative to room and board costs for au pairs Support $0.00 N/A
Senate Bill 159 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
Senate Bill 706 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
Senate Bill 1879 An Act to ensure more women serve on corporate boards of directors Neutral $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing Neutral $0.00 N/A
House Bill 629 An Act relative to pharmaceutical pricing Oppose $0.00 N/A
House Bill 1162 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 3654 An Act relative to compensation for victims of opioids Neutral $0.00 N/A
House Bill 4547 An Act authorizing and accelerating transportation investment Support $0.00 N/A
Senate Bill 120 An Act relative to consumer data privacy Neutral $0.00 N/A
Senate Bill 696 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 1701 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
Senate Bill 2769 An Act Putting Patients First Support $0.00 N/A
House Bill 949 An Act relative to non-medical switching Support $0.00 N/A
House Bill 1178 An Act relative to promoting transparency in the pharmaceutical industry Support $0.00 N/A
House Bill 1036 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 4806 Governor's Interim Spending Budget (FY2021) Neutral $0.00 N/A
Senate Bill 541 An Act relative to co-pay assistance Support $0.00 N/A
Senate Bill 712 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Senate Docket 2264 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability Neutral $0.00 N/A
House Bill 959 An Act requiring continual coverage of prescription medication Neutral $0.00 N/A
House Bill 1186 An Act strengthening HPC and CHIA market oversight Neutral $0.00 N/A
House Bill 1050 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
Executive Office of the Governor Order No. 13: Designates certain COVID Essential Services temporarily closed the brick and mortar premises of businesses and organizations that do not provide COVID-19 Essential Services, and prohibited gatherings of more than 10 people Neutral $0.00 N/A
Senate Bill 543 An Act reducing health care costs through improved medication management Support $0.00 N/A
Senate Bill 715 An Act relative to pharmaceutical price transparency and cost sharing Neutral $0.00 N/A
Senate Bill 563 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
House Bill 1148 An Act regarding Massachusetts drug price relief Oppose $0.00 N/A
House Bill 3481 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
House Bill 4508 An Act relative to transportation finance Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Bulletin 289: MassHealth Coverage and Reimbursement Policy for Services Related to COVID-19 Neutral $0.00 N/A
Senate Bill 653 An Act relative to prescription drug pricing Neutral $0.00 N/A
Senate Bill 1295 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
Senate Bill 2671 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
House Bill 915 An Act ensuring access to medications Neutral $0.00 N/A
House Bill 1167 An Act relative to prescription drug price transparency Oppose $0.00 N/A
House Bill 3877 An Act relative to capping the price of life saving prescription drugs Oppose $0.00 N/A
House Bill 4567 An Act relative to the application of the Domestic Workers Bill of Rights as it pertains to Au Pairs Support $0.00 N/A
Senate Bill 154 An Act relative to bad faith assertions of patent infringement Support $0.00 N/A
Senate Bill 703 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Senate Bill 1780 An Act relative to repealing the Employer Medical Assistance Contribution Supplement Tax Neutral $0.00 N/A
Senate Bill 2796 An Act Putting Patients First (Printed-as-amended version of SB2769) Support $0.00 N/A
House Bill 1016 An Act establishing a commission to study maximum allowable costs lists Neutral $0.00 N/A
House Bill 1853 An Act relative to fail first and patient safety Support $0.00 N/A
House Bill 4211 An Act to improve patient access to cancer clinical trial programs Support $0.00 N/A
House Bill Neutral $0.00 N/A
Senate Bill 582 An Act ensuring access to medications Neutral $0.00 N/A
Senate Bill 733 An Act relative to consumer protection for prescription drug purchases Support $0.00 N/A
Senate Bill 2397 Pharmaceutical Access, Costs and Transparency Oppose $0.00 N/A
House Bill 391 An Act relative to reprogrammed human skin cells for embryonic stem cell research Neutral $0.00 N/A
House Bill 1660 An Act promoting pay transparency and pipeline advancement Neutral $0.00 N/A
House Bill 3551 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
House Bill 4530 An Act relative to transportation finance Support $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) N/A Monitoring the Department of Public Health emergency order regarding modifications to pharmacy practice Neutral $0.00 N/A
Senate Bill 695 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Oppose $0.00 N/A
Senate Bill 1304 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
Senate Bill 2746 An Act financing improvements to municipal roads and bridges Support $0.00 N/A
House Bill 1062 An Act relative to transparent health care data Neutral $0.00 N/A
House Bill 1930 An Act providing for unused medication return by health care facilities Neutral $0.00 N/A
House Bill 4268 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
Executive Office of the Governor Order No. 35: Clarifies the progression of the Commonwealth’s Phased Workplace Re-Opening Plan and Authorizing certain re-opening preparations at Phase II workplaces Neutral $0.00 N/A
Senate Bill 611 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
Senate Bill 1206 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
Senate Bill 2433 An Act relative to step therapy and patient safety Support $0.00 N/A
House Bill 1088 An Act relative to prescription drug access Support $0.00 N/A
House Bill 1934 An Act to create a Massachusetts rare disease advisory council Neutral $0.00 N/A
House Bill 2 An Act making appropriations for the fiscal year 2021 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Executive Office of the Governor Order No. 591: Declaration of a State of Emergency to Respond to COVID-19 Neutral $0.00 N/A
Senate Bill 640 An Act to ensure access to generic medications Neutral $0.00 N/A
Senate Bill 1218 An Act relative to sharps stewardship Oppose $0.00 N/A
Senate Bill 2484 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
House Bill 966 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
House Bill 1192 An Act relative to the examination of health care cost trends in MassHealth Neutral $0.00 N/A
House Bill 1116 An Act relative to ensuring treatment for genetic craniofacial conditions Support $0.00 N/A
Executive Office of the Governor Order No. 21: Extends the period in which COVID-19 Order No. 13 would continue to restrict the operation of businesses and organizations that do not provide COVID-19 Essential Services Neutral $0.00 N/A
Senate Bill 552 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 721 An Act relative to mandatory prescription drug coverage Oppose $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John Heffernan
Client: Flexion Therapeutics, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Executive Department of Public Health (DPH) Monitoring Department of Public Health opioid regulations Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
DateLobbyist nameEvent typePayee/VendorAttendeesAmount
02/05/2020 John Heffernan Meal Capitol Coffee House John Heffernan;Robert Coughlin;Pat Cerundolo $50.41
03/12/2020 John Heffernan Meal Carrie Nation John Heffernan;Daniel Delaney;Diane Murad $52.87
03/09/2020 John Heffernan Travel City of Boston John Heffernan;Pat Cerundolo;Joseph Mascangioli $2.65
02/10/2020 John Heffernan Travel City of Cambridge John Heffernan;Robert Coughlin $3.00
03/02/2020 John Heffernan Travel Uber, from Boston to Cambridge John Heffernan;Susan Martin;Zachary Stanley $6.99
02/05/2020 John Heffernan Travel Boston Common Garage John Heffernan;Robert Coughlin;Pat Cerundolo $24.00
02/10/2020 John Heffernan Travel Boston Common Garage John Heffernan;Ken Sprague;Julie Haeber $24.00
01/09/2020 John Heffernan Travel Kendall Square Garage John Heffernan;Robert Coughlin $25.00
03/12/2020 John Heffernan Travel Boston Common Garage John Heffernan;John Pawn $28.00
03/13/2020 John Heffernan Travel Technology Square Garage John Heffernan;Robert Coughlin $30.00
01/30/2020 John Heffernan Travel 100 Cambridge Street Garage John Heffernan;Robert Coughlin;Marjorie Decker $41.00
01/10/2020 John Heffernan Travel Technology Square Garage John Heffernan;Zachary Stanley;Susan Martin $42.00
01/23/2020 John Heffernan Travel Technology Square Garage John Heffernan;Zachary Stanley;Susan Martin $42.00
03/02/2020 John Heffernan Travel PI Alley Garage John Heffernan;Susan Martin;Zachary Stanley $42.00
03/05/2020 John Heffernan Travel PI Alley Garage John Heffernan;Jon Santiago $42.00
01/29/2020 John Heffernan Travel PI Alley Garage John Heffernan;Angela Gochenaur;Patrick Plues $86.00
    Total amount $541.92
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateLobbyist nameRecipient nameOffice soughtAmount
03/03/2020 John Heffernan Jon Santiago State Representative $200.00
03/10/2020 John Heffernan Denise Garlick State Representative $200.00
03/11/2020 John Heffernan John Lawn State Representative $200.00
04/24/2020 John Heffernan Rob Consalvo State Representative $200.00
04/27/2020 John Heffernan Meghan Kilcoyne State Representative $100.00
05/28/2020 John Heffernan Daniel Ryan State Representative $200.00
05/28/2020 John Heffernan Dave Rogers State Representative $200.00
06/23/2020 John Heffernan Julian Cyr State Senator $200.00
   Total contributions $1,500.00
Close this page